During the past decade, Columbia University Medical Center New York Presbyterian Neuroendocrine Unit conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia University Medical Center New York Presbyterian Neuroendocrine Unit" #1 collaborator was "EMD Serono" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator, "New York Obesity and Nutrition Research Center" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Columbia University Medical Center New York Presbyterian Neuroendocrine Unit" are "Acromegaly" (3 trials), "Growth Hormone Deficiency" (3 trials), "Cushing's Disease" (2 trials), "Cushing's Syndrome" (2 trials) and "Pituitary Tumor" (2 trials). Many other conditions were trialed in "Columbia University Medical Center New York Presbyterian Neuroendocrine Unit" in a lesser frequency.

Most popular intervention types in "Columbia University Medical Center New York Presbyterian Neuroendocrine Unit" are "Drug" (8 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pasireotide LAR" (2 trials), "osilodrostat" (2 trials), "CTL019" (1 trials), "Growth hormone" (1 trials) and "Insulin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University Medical Center New York Presbyterian Neuroendocrine Unit" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Columbia University Medical Center New York Presbyterian Neuroendocrine Unit". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Columbia University Medical Center New York Presbyterian Neuroendocrine Unit, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University Medical Center New York Presbyterian Neuroendocrine Unit, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".